A patent infringement suit filed by King Pharmaceuticals, Inc. and
Elan Pharma International Ltd. against Actavis, Inc. relating to
Avinza (morphine sulfate) was settled in July 2011. The Company
acquired…
provides in-depth news coverage of intellectual property lawsuits involving public companies with assets of USD $1 billion or more. Coverage focuses on the infringement of intellectual property rights (including patents, copyrights, trademarks, trade dress, trade secrets, and royalties) and corporate indemnification of intellectual property violations.